BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24874088)

  • 1. Adverse surgical outcomes in screen-detected ductal carcinoma in situ of the breast.
    Thomas J; Hanby A; Pinder SE; Ball G; Lawrence G; Maxwell A; Wallis M; Evans A; Dobson H; Clements K; Thompson A;
    Eur J Cancer; 2014 Jul; 50(11):1880-90. PubMed ID: 24874088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiological and pathological size estimations of pure ductal carcinoma in situ of the breast, specimen handling and the influence on the success of breast conservation surgery: a review of 2564 cases from the Sloane Project.
    Thomas J; Evans A; Macartney J; Pinder SE; Hanby A; Ellis I; Kearins O; Roberts T; Clements K; Lawrence G; Bishop H;
    Br J Cancer; 2010 Jan; 102(2):285-93. PubMed ID: 20051953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project.
    Shaaban AM; Hilton B; Clements K; Provenzano E; Cheung S; Wallis MG; Sawyer E; Thomas JS; Hanby AM; Pinder SE; Thompson AM;
    Br J Cancer; 2021 Mar; 124(5):1009-1017. PubMed ID: 33199800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project.
    Thompson AM; Clements K; Cheung S; Pinder SE; Lawrence G; Sawyer E; Kearins O; Ball GR; Tomlinson I; Hanby A; Thomas JSJ; Maxwell AJ; Wallis MG; Dodwell DJ;
    Eur J Cancer; 2018 Sep; 101():210-219. PubMed ID: 30092498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.
    Duffy SW; Dibden A; Michalopoulos D; Offman J; Parmar D; Jenkins J; Collins B; Robson T; Scorfield S; Green K; Hall C; Liao XH; Ryan M; Johnson F; Stevens G; Kearins O; Sellars S; Patnick J
    Lancet Oncol; 2016 Jan; 17(1):109-14. PubMed ID: 26655422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy after mastectomy for screen-detected ductal carcinoma in situ.
    Clements K; Dodwell D; Lawrence G; Ball G; Francis A; Pinder S; Sawyer E; Wallis M; Thompson AM;
    Eur J Surg Oncol; 2015 Oct; 41(10):1406-10. PubMed ID: 26314790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cohort profile of the Sloane Project: methodology for a prospective UK cohort study of >15 000 women with screen-detected non-invasive breast neoplasia.
    Clements K; Dodwell D; Hilton B; Stevens-Harris I; Pinder S; Wallis MG; Maxwell AJ; Kearins O; Sibbering M; Shaaban AM; Kirwan C; Sharma N; Stobart H; Dulson-Cox J; Litherland J; Mylvaganam S; Provenzano E; Sawyer E; Thompson AM
    BMJ Open; 2022 Dec; 12(12):e061585. PubMed ID: 36535720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy.
    Tunon-de-Lara C; Giard S; Buttarelli M; Blanchot J; Classe JM; Baron M; Monnier B; Houvenaeghel G
    Breast J; 2008; 14(2):135-40. PubMed ID: 18315691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type and Extent of Surgery for Screen-Detected and Interval Cancers at Blinded Versus Nonblinded Double-Reading in a Population-Based Screening Mammography Program.
    Weber RJ; van Bommel RM; Setz-Pels W; Voogd AC; Klompenhouwer EG; Louwman MW; Strobbe LJ; Tjan-Heijnen VC; Duijm LE
    Ann Surg Oncol; 2016 Nov; 23(12):3822-3830. PubMed ID: 27334217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
    Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
    JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple re-excisions versus mastectomy in patients with persistent residual disease following breast conservation surgery.
    Cellini C; Huston TL; Martins D; Christos P; Carson J; Kemper S; Simmons RM
    Am J Surg; 2005 Jun; 189(6):662-6. PubMed ID: 15910716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].
    Piubello Q; Montemezzi S; D'Atri C
    Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time trends and inter-hospital variation in treatment and axillary staging of patients with ductal carcinoma in situ of the breast in the era of screening in Southern Netherlands.
    van Steenbergen LN; Voogd AC; Roukema JA; Louwman WJ; Duijm LE; Coebergh JW; van de Poll-Franse LV
    Breast; 2014 Feb; 23(1):63-8. PubMed ID: 24291376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of and treatment for ductal carcinoma in situ of the breast.
    Ernster VL; Barclay J; Kerlikowske K; Grady D; Henderson C
    JAMA; 1996 Mar; 275(12):913-8. PubMed ID: 8598618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Institutional variation in the surgical treatment of breast cancer: a study of the NCCN.
    Greenberg CC; Lipsitz SR; Hughes ME; Edge SB; Theriault R; Wilson JL; Carter WB; Blayney DW; Niland J; Weeks JC
    Ann Surg; 2011 Aug; 254(2):339-45. PubMed ID: 21725233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.
    Boyages J; Delaney G; Taylor R
    Cancer; 1999 Feb; 85(3):616-28. PubMed ID: 10091735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the volume of ductal carcinoma in situ impact the positive margin rate in patients undergoing breast conservation for invasive breast cancer?
    Martin-Dunlap TM; Cyr AE; Al Mushawah F; Gao F; Margenthaler JA
    J Surg Res; 2013 Sep; 184(1):228-33. PubMed ID: 23688789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urban-rural differences in the management of screen-detected invasive breast cancer and ductal carcinoma in situ in victoria.
    Kok DL; Chang JH; Erbas B; Fletcher A; Kavanagh AM; Henderson MA; Gertig DM
    ANZ J Surg; 2006 Nov; 76(11):996-1001. PubMed ID: 17054549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of subsequent invasive breast cancer after a diagnosis of ductal carcinoma in situ (DCIS).
    Cheung S; Booth ME; Kearins O; Dodwell D
    Breast; 2014 Dec; 23(6):807-11. PubMed ID: 25270228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospital organizational factors affect the use of immediate breast reconstruction after mastectomy for breast cancer in the Netherlands.
    Schreuder K; van Bommel ACM; de Ligt KM; Maduro JH; Vrancken Peeters MTFD; Mureau MAM; Siesling S
    Breast; 2017 Aug; 34():96-102. PubMed ID: 28552797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.